HUM

HUM

USD

Humana Inc. Common Stock

$231.800+1.210 (0.525%)

Preço em tempo real

Healthcare
Healthcare Plans
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$230.590

Máximo

$232.085

Mínimo

$227.760

Volume

1.51M

Fundamentos da empresa

Capitalização de mercado

28.0B

Setor

Healthcare Plans

País

United States

Estatísticas de negociação

Volume médio

1.76M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $212.45Atual $231.800Máximo $406.46

Notícias relacionadas

BusinessWire

Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age

Presenting sponsor of the National Senior Games announces the Humana Game Changer Class of 2025 As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE:HUM)

Ver mais
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $273 to $268.

Ver mais
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268
PR Newswire

New PPO Dental Plans More Competitive Against HMOs

DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum...

Ver mais
New PPO Dental Plans More Competitive Against HMOs
PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting...

Ver mais
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Reuters

Wall Street's potential winners and losers from Trump's tax bill

As President Donald Trump's sweeping tax-cut and spending bill heads to the Senate, analysts examine how his broad-ranging policies could turn the fortunes of U.S. companies if the package is enacted as law.

Ver mais
Wall Street's potential winners and losers from Trump's tax bill
Reuters

Humana to back curbs to Medicare Advantage billing practices, WSJ reports

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.

Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $322 to $273.

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.